End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,86,000 KRW | -1.21% | +12.16% | +190.36% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
ETFs positioned on ALTEOGEN Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 2 M€ | -14.14% | ||
0.02% | 4 M€ | -4.41% | - | |
0.01% | 7 M€ | +3.28% | - | |
0.00% | 114 M€ | +5.17% | - | |
0.00% | 36 M€ | +10.51% | - | |
0.00% | 324 M€ | +8.24% | - | |
0.00% | 40 M€ | +6.72% | - | |
0.00% | 32 M€ | +4.18% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+190.36% | 1.09TCr | |
+2.97% | 9.47TCr | |
-4.08% | 3.73TCr | |
-13.26% | 3.27TCr | |
+74.14% | 2.77TCr | |
-11.58% | 1.62TCr | |
-1.66% | 1.39TCr | |
-11.67% | 1.16TCr | |
-52.61% | 954.09Cr | |
+5.99% | 905.18Cr |
- Stock Market
- Equities
- A196170 Stock
- Funds and ETFs ALTEOGEN Inc.